• Mashup Score: 0
    Virtual - 8 month(s) ago

    ON-DEMAND Q: Will I be able to watch session recordings after the meeting has concluded? A: Session replay will be available once the event concludes if you purchase an on-demand package.  Q: What is included with the on-demand packages? A: When you register for the Plus or Premium Plus Package, you will have extended access to the sessions that were presented live plus additional access to…

    Tweet Tweets with this article
    • Expand your knowledge in the diagnosis and management of #HematologicMalignancies with our partners @GreatDebatesCME. The final debates are coming up on Aug 17-19 in Boston. View the full agenda and register now: https://t.co/CHe8ndaUPD #GDUHEM https://t.co/mdj3DT6CT7

  • Mashup Score: 1

    At the 2023 Great Debates & Updates in Hematologic Malignancies meeting in New York, New York, Andrew Artz, MD, participated in a debate about the benefits of hematopoietic stem cell transplantation among patients with AML with MRD after initial therapy.

    Tweet Tweets with this article
    • In a debate at the 2023 Great Debates & Updates in Hematologic Malignancies #GDUHem meeting, Andrew Artz, MD, highlighted the benefits of #HSCT among patients with #AML with #MRD after initial therapy. Learn more: https://t.co/bYy1IL5tcT… @GreatDebatesCME @cityofhope https://t.co/SwwPTzf7ga

  • Mashup Score: 0

    At the 2023 Great Debates & Updates in Hematologic Malignancies conference in New York, Richard Stone, MD, debated the role of measurable residual disease when considering hematopoietic stem cell transplantation for patients with acute myeloid leukemia.

    Tweet Tweets with this article
    • In a debate at the 2023 Great Debates & Updates in Hematologic Malignancies #GDUHem meeting, Richard Stone, MD, discussed the role of #MRD when considering #HSCT for patients with #AML. Follow along as he shares his insights! https://t.co/tEPPqkhfge… @GreatDebatesCME @DanaFarber https://t.co/vYp7HN2MgQ